Re-thinking drug pricing and value in health care through the lens of societal value

Written by Sreeram Ramagopalan (Lane Clark & Peacock)
Health policy Interviews Medical devices, pharmaceuticals and vaccines Outcomes research Peek Behind the Paper Value assessment

A new article by Peter Kolchinsky (RA Capital Management LP), Lou Garrison (The Comparative Health Outcomes, Policy, and Economics (CHOICE) Institute, University of Washington), Jose Diaz (Bristol Myers Squibb), and Sreeram Ramagopalan and Grace Mitchell (Lane Clark & Peacock LLP) aims to address some of the misunderstandings around the economics of the pharmaceutical industry. Advocated as a "required reading" for anyone interested in health policy, here we learn more about the paper from lead author Sreeram Ramagopalan. Stories about high drug prices always make the news, but there's never really any discussion as to what goes into drug pricing, and...

To view this content, please register now for access

It's completely free